TP53 and non-small cell lung carcinoma: In NSCLC cells, ROS-induced overexpression of heme oxygenase-1 (HMOX1) contributed to p53-mediated inhibition of miR-378 expression, which reduced VEGF expression and diminished angiogenic potential [173].